FDA has approved mitomycin (Jelmyto) for adult patients with low-grade upper tract urothelial cancer.
Merck April 15 introduced Ontruzant(trastuzumab-dttb), a biosimilar of the reference biologic medicine Herceptin, to the U.S. Ontruzant is available in both 150 mg single-dose vials and 420 mg multiple-dose vials.
Elicio Therapeutics and NCI are working together to characterize T cell responses to ELI-002 in animals.
Juul sales recovered within weeks following a dip after the company withdrew some flavored products from stores, eventually surpassing sales from before the change, according to a study by American Cancer Society researchers in the American Journal of Public Health.
New preclinical research from a team at Roswell Park Comprehensive Cancer Center suggests a strategy for significantly increasing both the local and distant, or “abscopal,” effects of radiation, according to a study.
AstraZeneca said it will initiate a randomized, global clinical trial to assess the potential of Calquence (acalabrutinib) in the treatment of the exaggerated immune response (cytokine storm) associated with COVID-19 infection in severely ill patients.
Enrolling patients in clinical trials at OneOncology partner practices has slightly increased in March and April, as the COVID-19 pandemic hit its communities hardest.
The American Cancer Society is inviting participants to join its ongoing Cancer Prevention Study 3 (CPS-3) to use a new app to help investigators track the COVID-19 epidemic and inform future research efforts.
Research!America is urging Congress to modify the budget caps and increase funding for health agencies for FY21 in light of the COVID-19 pandemic.
The presidents of the National Academy of Sciences, National Academy of Engineering, and National Academy of Medicine are urging the U.S. government to continue funding for the World Health Organization during the COVID-19 pandemic. NAS President Marcia McNutt, NAE President John L. Anderson, and NAM President Victor J. Dzau wrote the following:
